Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glory Health IndustryFRA:84R -9.09%35 EBITDA Margin % is -131.20% as of Dec. 2025. GuruFocus rates FRA:84R with a GF Score™ of 35/100. The stock has 5 warning signs investors should review. Among 1,751 Real Estate companies, Glory Health Industry ranks worse than 92.69% on this metric.
Glory Health Industry (FRA:84R) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Glory Health Industry EBITDA Margin % Related Terms
Glory Health Industry EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Glory Health Industry's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glory Health Industry EBITDA Margin % Competitor Comparison
For the Real Estate - Development subindustry, Glory Health Industry's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glory Health Industry EBITDA Margin % vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Glory Health Industry's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Glory Health Industry's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glory Health Industry (FRA:84R) has a EBITDA Margin % of -131.20% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Glory Health Industry and its competitors. According to the industry distribution chart, Glory Health Industry ranks #1623 out of 1751 companies in the Real Estate industry, placing it in the top 92.7%.
Is Glory Health Industry's EBITDA Margin % too high?
Glory Health Industry's current EBITDA Margin % is -131.20%. Based on the distribution chart, Glory Health Industry ranks #1623 out of 1751 companies in the Real Estate industry, which is in the bottom quartile relative to peers. Overall, Glory Health Industry has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Glory Health Industry's EBITDA Margin % compare to competitors?
According to the Real Estate industry distribution chart, Glory Health Industry ranks #1623 out of 1751 companies for EBITDA Margin %. This places Glory Health Industry in the lower half of its industry. The industry median EBITDA Margin % is 20.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Real Estate company?
The median EBITDA Margin % among Real Estate companies is 20.93, based on 1,751 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Glory Health Industry and its competitors. For the Real Estate industry, the median EBITDA Margin % is 20.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glory Health Industry's current EBITDA Margin % is -131.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glory Health Industry stock overvalued right now?
Glory Health Industry (FRA:84R) has a current EBITDA Margin % of -131.20%. The current EBITDA Margin % is -131.20%. Glory Health Industry's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Glory Health Industry (FRA:84R), the current EBITDA Margin % is -131.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glory Health Industry Ltd is an investment holding company. The company's operating segments are Property development that develops and sells commercial and residential properties; primary land construction and development services that derive revenue from primary land development, including services for resettlement, construction of land infrastructure, and ancillary public facilities on land owned by the local governments; Property investment that derives rental income from investment properties developed by the group; and Property management that derive income from property management and related services. The majority of the revenue is derived from the Property development segment. All the company's revenue is derived from the PRC.
35GF Score
Get the complete analysis for FRA:84R
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:84R has been successfully added to your 
